UroToday12h
ESMO 2024: Invited Discussant: Efficacy of SPLASH and UpFrontPSMA Trials
(UroToday.com) The 2024 European Society for Medical Oncology (ESMO) Annual Congress held in Barcelona, Spain between September 13 th and 16 th, 2024 was host to a proffered paper session for prostate ...
UroToday16h
ESMO 2024: Controversies in Testis Cancer: Escalation or De-escalation?
(UroToday.com) The 2024 European Society for Medical Oncology (ESMO) Annual Congress held in Barcelona, Spain between September 13 th and 16 th, 2024 was host to a session focusing on rare ...
UroToday16h
ESMO 2024: Updates in Penile Cancer
(UroToday.com) The 2024 European Society for Medical Oncology (ESMO) Annual Congress held in Barcelona, Spain between September 13 th and 16 th, 2024 was host to a session focusing on rare ...
UroToday16h
ESMO 2024: Prospective COTRIMS (COlogne Trial of Retroperitoneal Lymphadenectomy in Metastatic Seminoma) Trial – 3 Year Update
(UroToday.com) The 2024 ESMO annual meeting included a session on testicular cancer, featuring a presentation by Dr. Axel Heidenreich discussing the 3 year update of the prospective COTRIMS trial.
UroToday16h
ESMO 2024: Assessment of the Utility of CT Scans in the Long-Term Follow-up of Metastatic Non-Seminomatous Germ Cell Tumors: The Late CT Study
(UroToday.com) The 2024 ESMO annual meeting included a session on testicular cancer, featuring a presentation by Dr. Deep Chakrabarti discussing the Late CT study assessing the utility of CT scans in ...